Arrowhead Pharmaceuticals (ARWR) Net Margin (QoQ) (2012 - 2026)

Arrowhead Pharmaceuticals (ARWR) Net Margin (QoQ) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Arrowhead Pharmaceuticals 11.98 Bn 10.18 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -19,727.00
Dec 31, 2025 441.00
Sep 30, 2025 64,982.00
Jun 30, 2025 -71,131.00
Mar 31, 2025 707,650.00
Dec 31, 2023 -312,267.00
Sep 30, 2023 -3,168.00
Jun 30, 2023 -69,057.00
Mar 31, 2023 9,942.00
Dec 31, 2022 20,536.00
Sep 30, 2022 -4,990.00
Jun 30, 2022 -25,151.00
Mar 31, 2022 25,836.00
Dec 31, 2021 -6,359.00
Sep 30, 2021 -10,033.00
Jun 30, 2021 1,653.00
Mar 31, 2021 1,558.00
Dec 31, 2020 53,719.00
Sep 30, 2020 -58,479.00
Jun 30, 2020 3,459.00